E Fund Biopharma ETF(03186.HK) rose 0.85% in the afternoon, with a trading volume of approximately HK$224,000
NewTimeSpace News: As of 13:45 on May 11,E Fund Biopharma ETF(03186.HK) went up 0.85% at HK$15.48. Its turnover reached about HK$224,000 with a trading volume of 14,700 lots and an amplitude of 1.89%. The premium rate stood at -0.06%, and the net asset value per unit was HK$15.359.The ETF has an asset size of approximately HK$30.7177 million, with a total issued share capital of 2 million shares and a turnover rate of 0.74%. Each board lot consists of 100 shares.
E Fund Biopharma ETF(03186.HK) tracks the Solactive Biopharma Select Index. The index selects 100 constituent stocks from biopharmaceutical companies listed in Hong Kong and the United States, covering major global innovation hubs including China, the United States, Europe and Israel.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- VIRTUAL MIND (01520.HK): Forms Joint Venture with Gou Si Technology to Expand AI and Continuous Learning Business, Holding 51% Equity
- CIRC (01763.HK): General Manager Zhang Junqi Resigns, Li Penghui Appointed as Successor
- CHONGQING M&E (02722.HK): Wholly-Owned Subsidiary Files for Bankruptcy Liquidation, Court Acceptance Uncertain
- XH NEWS MEDIA (00309.HK): Winding-up Petition Withdrawn as HKD 588,808 Debt Fully Settled
- TONG REN TANG (01666.HK): Subsidiary Obtains Certificate of Registration for Chinese Patent Medicine, Sanzi Yangqin Granules to Be Sold in Hong Kong